Literature DB >> 17496575

Prognostic scoring systems: which one is best?

Charles Feldman1.   

Abstract

PURPOSE OF REVIEW: In the initial evaluation of patients with community-acquired pneumonia, a number of important assessments are made, including that of the severity of the illness. This assessment will determine the appropriate site of care, diagnostic work-up, and choice of empiric antibiotics. A number of severity assessment tools have been developed and some of the recent findings are reviewed. RECENT
FINDINGS: A number of studies of the efficacy of the individual scoring systems, as well as comparator studies, have been undertaken. A significant number of patients with community-acquired pneumonia in Pneumonia Severity Index classes I and II are admitted to hospital and several of these patients suffer complications. Clinical and social factors other than those contained in the scoring systems need to be taken into consideration when deciding about hospitalization of patients with community-acquired pneumonia. A number of studies of the efficacy of the various scoring systems in predicting 'severe pneumonia' have been undertaken, as well as studies of their accuracy in the sub-set of patients with pneumococcal infections and in the elderly.
SUMMARY: The various scoring systems have reasonable sensitivity and specificity and their own strengths and weaknesses, but should always be used in association with good clinical judgment.

Entities:  

Mesh:

Year:  2007        PMID: 17496575     DOI: 10.1097/QCO.0b013e328014da75

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  4 in total

1.  Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective study.

Authors:  Ying Su; Min-Jie Ju; Jie-Fei Ma; Guo-Wei Tu; Hong-Yu He; Zhun-Yong Gu; Yuan-Lin Song; Jing Zhang; Zhe Luo
Journal:  Ann Transl Med       Date:  2019-11

2.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

Review 3.  Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.

Authors:  Helen C Steel; Riana Cockeran; Ronald Anderson; Charles Feldman
Journal:  Mediators Inflamm       Date:  2013-12-25       Impact factor: 4.711

4.  PROGRESS - prospective observational study on hospitalized community acquired pneumonia.

Authors:  Peter Ahnert; Petra Creutz; Markus Scholz; Hartwig Schütte; Christoph Engel; Hamid Hossain; Trinad Chakraborty; Michael Bauer; Michael Kiehntopf; Uwe Völker; Sven Hammerschmidt; Markus Loeffler; Norbert Suttorp
Journal:  BMC Pulm Med       Date:  2016-07-28       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.